2m 2m 2m 2m 2m 2m 2m
Arco Biomedcl Co (ACBM)
OTC
$0.03$0.00 (0.00%)
Price as of Apr 20, 2026- $1.6MMarket Cap
- 3,614.29%1-Year Change
- Shell CompaniesIndustry
Arco Biomedcl Co (ACBM)
$0.03$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 N/A | 0 N/A | 0 -100.00% | 658,500 -45.01% | |
Cost of Revenue | N/A N/A | N/A N/A | 0 -100.00% | 518,000 -44.78% | |
Gross Profit | 0 N/A | 0 N/A | 0 -100.00% | 140,500 -45.86% | |
Sales and Marketing Expense | 154,024 +305.77% | 37,958 -98.92% | 3.5M -40.68% | 5.9M +122.28% | |
Research and Development Expense | N/A N/A | 0 +100.00% | -4.8M -52.43% | -10.1M +90.72% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 154,024 +305.77% | 37,958 -99.57% | 8.8M -45.01% | 16.0M +101.31% | |
Operating Profit | -154,024 +305.77% | -37,958 -99.57% | -8.8M -44.52% | -15.9M +106.27% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -3,206 +795.53% | -358 -59.91% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -3,206 +795.53% | -358 -59.91% | |
Total Nonoperating Income and Expense | 52,878 N/A | N/A N/A | 3,206 +795.53% | 358 -59.91% | |
Income before Taxes | -101,146 +139.13% | -42,297 -99.52% | -8.8M -44.50% | -15.9M +106.27% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -101,146 +139.13% | -42,297 -99.52% | -8.8M -44.51% | -15.9M +106.18% | |
Net Income from Continuing Operations Applicable to Common | -101,146 +139.13% | -42,297 -99.52% | -8.8M -44.51% | -15.9M +106.18% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | 0.00 N/A | 0.00 +100.00% | -0.15 N/A | N/A N/A | |
Basic Weighted Average Shares | 60.0M 0.00% | 60.0M 0.00% | 60.0M 0.00% | 60.0M +11.52% | |
Diluted Weighted Average Shares | 60.0M 0.00% | 60.0M 0.00% | 60.0M N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4,098 +760.92% | 476 +26.60% | 376 -93.57% | 5,852 -93.86% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4,098 +760.92% | 476 +26.60% | 376 -93.57% | 5,852 -93.86% | |
Total Current Assets | 14,098 +177.74% | 5,076 +212.18% | 1,626 -99.75% | 657,537 -6.92% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Assets | 14,098 -55.91% | 31,974 -45.31% | 58,459 -91.50% | 687,486 -9.67% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 78,826 +280.05% | |
Total Current Liabilities | 401,062 +22.67% | 326,946 +13.30% | 288,575 +43.49% | 201,116 +119.44% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | N/A N/A | 0 -100.00% | 26,898 N/A | 0 -100.00% | |
Total Liabilities | 401,062 +22.67% | 326,946 +3.64% | 315,473 +56.86% | 201,116 +71.35% | |
Retained Earnings | -32.8M +0.31% | -32.7M +0.13% | -32.6M +36.99% | -23.8M +199.98% | |
Total Stockholders Equity | -386,964 +31.19% | -294,972 +14.77% | -257,014 -152.84% | 486,370 -24.44% | |
Total Shares Outstanding | 60.0M 0.00% | 60.0M 0.00% | 60.0M 0.00% | 60.0M +25.72% | |
Cash Flow | |||||
Cash from Operating Activities | -196,302 +435.00% | -36,692 +137.55% | -15,446 -89.53% | -147,481 -149.27% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 199,924 +443.39% | 36,792 +269.03% | 9,970 -82.84% | 58,085 +126.14% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | 21.34% -1.54% | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | -2,409.98% +275.11% | |
Return on Assets | -439.08% +369.38% | -93.54% -96.04% | -2,361.45% +7.76% | -2,191.34% +150.39% | |
Return on Equity | 29.66% +93.56% | 15.33% +100.20% | -7,680.26% +173.42% | -2,808.91% +142.58% | |
Revenue Growth | N/A N/A | N/A N/A | -100.00% +122.17% | -45.01% -160.77% | |
Current Ratio | 0.04 +127.10% | 0.02 +176.79% | 0.006 -99.83% | 3.27 -57.58% | |
Cash Ratio | 0.01 +580.00% | 0.002 +15.38% | 0.001 -95.53% | 0.03 -97.20% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow